FACTORS ASSOCIATED WITH CHRONIC-RENAL-FAILURE IN 121 PATIENTS WITH DIFFUSE PROLIFERATIVE LUPUS-NEPHRITIS - A CASE-CONTROL STUDY

被引:34
作者
ARCESALINAS, CA
VILLA, AR
MARTINEZRUEDA, JO
MUNOZ, L
CARDIEL, MH
ALCOCERVARELA, J
ALARCONSEGOVIA, D
机构
[1] INST NACL NUTR SALVADOR ZUBIRAN,DEPT IMMUNOL & RHEUMATOL,MEXICO CITY 14000,DF,MEXICO
[2] INST NACL NUTR SALVADOR ZUBIRAN,DEPT PATHOL,MEXICO CITY 14000,DF,MEXICO
关键词
NEPHRITIS; PROGNOSTIC FACTORS; DIFFUSE PROLIFERATIVE GLOMERULONEPHRITIS;
D O I
10.1177/096120339500400306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lupus nephritis remains an important problem in patients with systemic lupus erythematosus (SLE). Some patients with diffuse proliferative lupus nephritis (DPLN) develop chronic renal failure (CRF). A case-control study was designed to determine the variables associated with CRF in patients with DPLN. We studied 121 patients with biopsy-proven DPLN seen in our institution from 1970 to 1988. There were 34 patients who developed CRE the remaining were their controls. Clinical charts were reviewed and a pathologist re-scored blindly both activity and chronicity indices. The mean of age at SLE onset was 24.1 +/- 7.9 years; the mean disease duration was 9.2 +/- 6.1 years for controls and 6.1 +/- 5 years for patients. The main variables associated with CRF were male sex, HR (hazard ratio): 12.6 (95% CI 1.6-98.2); activity index, HR 2.59 (1.07-6.3); severe infections, HR 2.9 (1.2-7.3); number of antihypertensive drugs, HR 2.5 (1.4-4.7); cellular crescents, HR 1.6 (1.2-2); and interstitial inflammation, HR 2.7 (1.5-5.1). A protective effect was observed with longer use of less than or equal to 20 mg of prednisone, HR 0.53 (95% CI 0.34-0.8); azathioprine, HR 0.6 (0.4-0.8); and length of formal education, HR 0.3 (0.09-0.94). Our results indicate that maleness, activity index, extracapillary proliferation and interstitial inflammation, as well as hypertension and severe infections associate with CRF in patients with DPLN, and treatment and higher education, perhaps through better therapeutic compliance, may be protective.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 59 条
[1]   CYCLOPHOSPHAMIDE (CYTOXAN) - A REVIEW ON RELEVANT PHARMACOLOGY AND CLINICAL USES [J].
AHMED, AR ;
HOMBAL, SM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 11 (06) :1115-1126
[2]   ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE ANALYSIS OF 500 CONSECUTIVE PATIENTS [J].
ALARCONSEGOVIA, D ;
DELEZE, M ;
ORIA, CV ;
SANCHEZGUERRERO, J ;
GOMEZPACHECO, L ;
CABIEDES, J ;
FERNANDEZ, L ;
DELEON, SP .
MEDICINE, 1989, 68 (06) :353-365
[3]   PRELIMINARY CLASSIFICATION CRITERIA FOR THE ANTIPHOSPHOLIPID SYNDROME WITHIN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALARCONSEGOVIA, D ;
PEREZVAZQUEZ, ME ;
VILLA, AR ;
DRENKARD, C ;
CABIEDES, J .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1992, 21 (05) :275-286
[4]   LUPUS NEPHRITIS - CORRELATION OF INTERSTITIAL-CELLS WITH GLOMERULAR FUNCTION [J].
ALEXOPOULOS, E ;
SERON, D ;
HARTLEY, RB ;
CAMERON, JS .
KIDNEY INTERNATIONAL, 1990, 37 (01) :100-109
[5]   LONG-TERM FOLLOW-UP OF PATIENTS WITH LUPUS NEPHRITIS - A STUDY BASED ON THE CLASSIFICATION OF THE WORLD-HEALTH-ORGANIZATION [J].
APPEL, GB ;
COHEN, DJ ;
PIRANI, CL ;
MELTZER, JI ;
ESTES, D .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (05) :877-885
[6]   PROGNOSTIC FACTORS IN LUPUS NEPHRITIS - CONTRIBUTION OF RENAL HISTOLOGIC DATA [J].
AUSTIN, HA ;
MUENZ, LR ;
JOYCE, KM ;
ANTONOVYCH, TA ;
KULLICK, ME ;
KLIPPEL, JH ;
DECKER, JL ;
BALOW, JE .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (03) :382-391
[7]   THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS [J].
AUSTIN, HA ;
KLIPPEL, JH ;
BALOW, JE ;
LERICHE, NGH ;
STEINBERG, AD ;
PLOTZ, PH ;
DECKER, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) :614-619
[8]  
AUSTIN HA, 1984, KIDNEY INT, V26, P689
[9]   CLINICAL COURSE OF PROLIFERATIVE AND MEMBRANOUS FORMS OF LUPUS NEPHRITIS [J].
BALDWIN, DS ;
LOWENSTEIN, J ;
ROTHFIELD, NF ;
GALLO, G ;
MCCLUSKEY, RT .
ANNALS OF INTERNAL MEDICINE, 1970, 73 (06) :929-+
[10]  
BALDWIN DS, 1982, AM J KIDNEY DIS, V2, P142